FTC, FDA Warn Companies about Marketing and Selling Opioid Cessation Products

Federal Trade Commission press release --------- The Federal Trade Commission and the U.S. Food and Drug Administration (FDA) today posted warning letters to the marketers and distributors of 11 opioid cessation products for illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and withdrawal.“Opioid addiction is a serious health epidemic that affects millions of Americans,” said Acting FTC Chairman Maureen K. Ohlhausen. “Individuals and their loved ones who struggle with this disease need real help, not unproven treatments. We will continue to work together with the FDA to address this important issue.” To get more in depth information click on the picture below to read the release.